Did Federal Officials Ignore Drug Intelligence on Legal Marijuana Markets?
Washington, Tuesday, 18 August 2026.
A new investigation questions whether federal officials ignored drug intelligence about criminal exploitation in state-legal marijuana markets, highlighting a massive 28-ton black-market seizure at a licensed facility.
Scrutiny Over Federal Intelligence and Attorney General Order
On Tuesday, 18 August 2026, MMJ International Holdings, Inc. released the first installment of a two-part examination challenging federal assertions regarding state-legal cannabis markets [1]. The report questions whether the White House and the U.S. Attorney General overlooked federal intelligence reports concerning the diversion of legal cannabis into illicit markets through state-licensed systems [1]. This development arises 8 - 4 = 4 months after the Attorney General issued Order No. 6754-2026 in April 2026, which determined that state-level medical marijuana systems possess a sustained capacity to prevent diversion [1]. MMJ disputes this finding, citing documented issues including criminal organization infiltration, inventory discrepancies, and deficient seed-to-sale tracking [1]. The company is demanding transparency from the Department of Justice, DEA, and ONDCP regarding the intelligence used to support the order [1].
Evidence of Diversion in State-Licensed Facilities
The investigation highlights specific instances of criminal exploitation within state-authorized businesses, particularly in Oklahoma, California, Oregon, Colorado, and Washington [1]. Evidence presented includes a federal prosecution in Oklahoma involving 28 tons of black-market marijuana and the seizure of 19,661 plants alongside over $100,000 in cash at an Oklahoma Medical Marijuana Authority-licensed facility [1]. An anonymous U.S. Attorney noted that a license under state law is not a license to traffic tons of black-market marijuana inside or outside Oklahoma [1]. Duane Boise, CEO of MMJ International Holdings, stated that DEA and HIDTA intelligence personnel knew criminal organizations were exploiting legal-marijuana states, though it remains unclear if that intelligence reached the Attorney General’s desk [1]. The HIDTA program, established by the Anti-Drug Abuse Act of 1988, operates 33 regional centers with over 1,500 dedicated DEA special-agent positions [1].
Implications for Federal Policy and Future Investigations
MMJ intends to release a second report examining five additional states, including Michigan, Massachusetts, Missouri, Nevada, and New York [1]. [alert! ‘specific reason’: No specific date provided for Part Two release, status unknown] This follow-up will investigate whether the Department of Justice and White House reviewed intelligence from the High Intensity Drug Trafficking Areas program before issuing the Attorney General’s order [1]. The findings come at a critical juncture for the cannabis industry, as executive administration policy directly impacts federal rescheduling efforts, interstate commerce regulations, and banking access for legal operators [1]. MMJ notes that before state licenses become federal passports into Schedule III, the Attorney General and the White House should disclose what they knew and when they knew it [1]. The company holds two Investigational New Drug files with the FDA and a DEA Schedule I analytical-laboratory registration [1].